Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 57Pancreatic Neoplasms 39Carcinoma, Non-Small-Cell Lung 29Triple Negative Breast Neoplasms 20Neoplasms 17Neoplasm Metastasis 11Lung Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Ovarian Neoplasms 8Melanoma 7Head and Neck Neoplasms 6Breast Neoplasms, Male 6Adenocarcinoma 6Urinary Bladder Neoplasms 5Inflammatory Breast Neoplasms 5Carcinoma 5Sarcoma 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Pancreatic Diseases 4Fallopian Tube Neoplasms 4Cholangiocarcinoma 4Carcinoma, Ovarian Epithelial 4Stomach Neoplasms 3Small Cell Lung Carcinoma 3Pancreatic Adenocarcinoma 3Esophageal Neoplasms 3Endocrine System Diseases 3Endocrine Gland Neoplasms 3Digestive System Neoplasms 3Digestive System Diseases 3

Interventions

Bevacizumab 112Fluorouracil 98Oxaliplatin 96Leucovorin 96Irinotecan 86Capecitabine 73Cetuximab 64Panitumumab 42pembrolizumab 38regorafenib 28Nivolumab 23IFL protocol 22Folfox protocol 21trifluridine tipiracil drug combination 14Radiotherapy 13durvalumab 11Gemcitabine 10Celecoxib 10tremelimumab 7binimetinib 7aflibercept 7Drug Therapy 7Disulfides 7Cyclophosphamide 7Trifluridine 6Trastuzumab 6Sunitinib 6Paclitaxel 6Immunoglobulin G 6Colonoscopy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Colorectal Neoplasms × Albumin-Bound Paclitaxel × Clear all
NCT04068896 2025-05-29

Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy

NGM Biopharmaceuticals, Inc

Phase 1/2 Completed
89 enrolled 21 charts
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02103062 2020-04-21

Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal Cancer

Celgene

Phase 2 Completed
41 enrolled 10 charts
Gastrointestinal

Colorectal Neoplasms

NCT01730586 2020-01-18

Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas

M.D. Anderson Cancer Center

Phase 2 Completed
34 enrolled 7 charts
Gastrointestinal

Gastrointestinal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡